Clinical Trial
High-dose methotrexate with citrovorum factor rescue: predictive value of serum methotrexate concentrations and corrective measures to avert toxicity
- PMID: 302143
Item in Clipboard
Clinical Trial
High-dose methotrexate with citrovorum factor rescue: predictive value of serum methotrexate concentrations and corrective measures to avert toxicity
Cancer Treat Rep.
1977 Aug.
No abstract available
Similar articles
-
Phase I trial of high-dose methotrexate with modified citrovorum factor rescue.Cancer Treat Rep. 1978 Mar;62(3):397-9. Cancer Treat Rep. 1978. PMID: 348306 Clinical Trial. No abstract available.
-
High-dose methotrexate with folinic acid rescue.Am J Hosp Pharm. 1977 Sep;34(9):961-5. Am J Hosp Pharm. 1977. PMID: 333910 Review.
-
"Single"-agent activity of high-dose methotrexate with citrovorum factor rescue.Cancer Treat Rep. 1978 Feb;62(2):233-5. Cancer Treat Rep. 1978. PMID: 305823 No abstract available.
-
High-dose methotrexate-citrovorum factor rescue in the management of brain tumors.Cancer Treat Rep. 1977 Jul;61(4):691-4. Cancer Treat Rep. 1977. PMID: 301782 No abstract available.
-
Antineoplastic agents: high-dose methotrexate and citrovorum factor rescue.Ther Drug Monit. 1980;2(2):177-85. Ther Drug Monit. 1980. PMID: 6762711 Review.
Cited by
-
Effect of serum albumin level on high-dose methotrexate induced toxicities in acute lymphoblastic leukemia patients.Int J Health Sci (Qassim). 2023 Mar-Apr;17(2):3-9. Int J Health Sci (Qassim). 2023. PMID: 36891042 Free PMC article.
-
Effect of glutamine on methotrexate efficacy and toxicity.Ann Surg. 1998 May;227(5):772-8; discussion 778-80. doi: 10.1097/00000658-199805000-00018. Ann Surg. 1998. PMID: 9605669 Free PMC article. Clinical Trial.
-
Interaction of 5'-deoxy-5-fluorouridine and methotrexate. A basis for reduced methotrexate toxicity.Arch Toxicol. 1989;63(5):401-5. doi: 10.1007/BF00303130. Arch Toxicol. 1989. PMID: 2530962
-
An indication of possible impending toxicity during moderately high dose methotrexate infusions.Br J Clin Pharmacol. 1978 Dec;6(6):551-2. doi: 10.1111/j.1365-2125.1978.tb00887.x. Br J Clin Pharmacol. 1978. PMID: 569491 Free PMC article. No abstract available.
-
Modelling and simulation in the development and use of anti-cancer agents: an underused tool?J Pharmacokinet Pharmacodyn. 2004 Dec;31(6):419-40. doi: 10.1007/s10928-005-5910-2. J Pharmacokinet Pharmacodyn. 2004. PMID: 16222783 Review.